Sublingual-oral administration of standardized allergenic extracts: phase 1 safety and dosing results

Daily sublingual-oral dosing of standardized allergenic extracts at maximum tolerable doses was generally well tolerated. These results are a first step toward establishing the safety of US-licensed SLIT extracts when appropriately self-administered and monitored.